Total Payments
$1,559
2024 Payments
$309.22
Companies
23
Transactions
66
Medicare Patients
5,623
Medicare Billing
$407,574
Payment Breakdown by Category
Food & Beverage$1,559 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,559 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $254.30 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $169.30 | 8 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $162.42 | 8 | $0 (2024) |
| Oyster Point Pharma, Inc. | $159.58 | 4 | $0 (2024) |
| Allergan Inc. | $153.12 | 2 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $96.88 | 2 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $96.27 | 5 | $0 (2024) |
| Shire North American Group Inc | $85.95 | 7 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $55.77 | 1 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $51.08 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $309.22 | 11 | Oyster Point Pharma, Inc. ($143.73) |
| 2023 | $325.23 | 18 | UCB, Inc. ($154.74) |
| 2022 | $334.11 | 15 | UCB, Inc. ($74.19) |
| 2021 | $62.46 | 3 | Novartis Pharmaceuticals Corporation ($23.03) |
| 2020 | $23.37 | 1 | Novartis Pharmaceuticals Corporation ($23.37) |
| 2019 | $213.60 | 7 | Allergan Inc. ($122.27) |
| 2018 | $231.43 | 7 | Aerie Pharmaceuticals, Inc. ($75.74) |
| 2017 | $59.86 | 4 | Allergan Inc. ($30.85) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch & Lomb Americas Inc. | BIOTRUE (Device) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: SOLUTION/ DROPS | ||||||
| 08/21/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: OPTOMETRY | ||||||
| 06/27/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $97.79 | General |
| Category: Dry eyes | ||||||
| 06/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Ophthalmology | ||||||
| 06/05/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: Dry eyes | ||||||
| 04/15/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Immunology | ||||||
| 01/29/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Ophthalmology | ||||||
| 01/18/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Dry eyes | ||||||
| 01/16/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Biosimilars | ||||||
| 10/24/2023 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: DERMATOLOGY | ||||||
| 08/23/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Immunology | ||||||
| 08/08/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Immunology | ||||||
| 07/28/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Ophthalmology | ||||||
| 06/22/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Immunology | ||||||
| 06/19/2023 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), PROLENSA | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Ophthalmology | ||||||
| 06/06/2023 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $13.64 | General |
| 05/25/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $7.47 | General |
| Category: Immunology | ||||||
| 05/17/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Ophthalmology | ||||||
| 05/16/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Dermatology | ||||||
| 05/02/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Immunology | ||||||
| 05/01/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Ophthalmology | ||||||
| 04/27/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Immunology | ||||||
| 03/07/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,357 | 4,860 | $192,970 | $99,096 |
| 2022 | 13 | 1,460 | 5,641 | $205,156 | $104,532 |
| 2021 | 13 | 1,440 | 5,027 | $203,764 | $112,198 |
| 2020 | 13 | 1,366 | 5,060 | $182,960 | $91,749 |
Total Patients
5,623
Total Services
20,588
Medicare Billing
$407,574
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 454 | 476 | $60,928 | $35,876 | 58.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 208 | $27,040 | $17,139 | 63.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 270 | $25,830 | $14,330 | 55.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 161 | 184 | $16,192 | $10,097 | 62.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 33 | 42 | $16,800 | $9,710 | 57.8% |
| 92250 | Photography of the retina | Office | 2023 | 153 | 154 | $12,320 | $3,592 | 29.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 33 | 3,380 | $23,100 | $3,216 | 13.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 20 | 20 | $3,040 | $1,731 | 57.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 40 | $2,290 | $1,278 | 55.8% |
| 92134 | Imaging of retina | Office | 2023 | 31 | 36 | $1,800 | $930.55 | 51.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 18 | 18 | $1,584 | $740.96 | 46.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 15 | 18 | $846.00 | $249.36 | 29.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 14 | 14 | $1,200 | $206.92 | 17.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 506 | 519 | $66,432 | $37,813 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 308 | 441 | $39,690 | $24,027 | 60.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 187 | 204 | $26,520 | $17,882 | 67.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 24 | 31 | $12,400 | $7,314 | 59.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 84 | 90 | $7,920 | $4,699 | 59.3% |
| 92250 | Photography of the retina | Office | 2022 | 177 | 177 | $14,160 | $3,922 | 27.7% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 36 | 4,023 | $26,400 | $3,694 | 14.0% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 22 | 22 | $3,344 | $1,840 | 55.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 32 | $1,760 | $1,071 | 60.8% |
| 92134 | Imaging of retina | Office | 2022 | 23 | 24 | $1,200 | $692.94 | 57.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 21 | 21 | $1,848 | $690.98 | 37.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 23 | 31 | $1,457 | $558.83 | 38.4% |
About Dr. William Helwig, M.D
Dr. William Helwig, M.D is a Ophthalmology healthcare provider based in Warren, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275533564.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Helwig, M.D has received a total of $1,559 in payments from pharmaceutical and medical device companies, with $309.22 received in 2024. These payments were reported across 66 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,559).
As a Medicare-enrolled provider, Helwig has provided services to 5,623 Medicare beneficiaries, totaling 20,588 services with total Medicare billing of $407,574. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Warren, OH
- Active Since 07/28/2005
- Last Updated 03/30/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1275533564
Products in Payments
- XIIDRA (Drug) $241.53
- Cimzia (Drug) $228.93
- TYRVAYA (Drug) $159.58
- Cequa (Drug) $143.38
- LUMIGAN (Drug) $122.27
- Rhopressa (Drug) $75.74
- BEVYXXA (Drug) $55.77
- BELSOMRA (Drug) $51.08
- DUPIXENT (Biological) $41.65
- ADBRY (Biological) $33.51
- VYZULTA (Drug) $32.97
- Bimzelx (Biological) $25.37
- BIOTRUE (Device) $25.00
- ACTHAR (Biological) $24.78
- VEVYE (Drug) $24.21
- TOTAL30 (Device) $24.06
- INFUSE (Device) $22.73
- rocklatan (Drug) $21.14
- IDACIO (Biological) $19.46
- XELPROS (Drug) $19.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Warren
Thomas Spoor, Md, MD
Ophthalmology — Payments: $17,448
Ophthalmology $17,448
Dr. Dominick Zangari, Md, MD
Ophthalmology — Payments: $7,477
Ophthalmology $7,477
Daniel Lin, Md, MD
Ophthalmology — Payments: $6,687
Ophthalmology $6,687
Dr. Alan Parent, M.d, M.D
Ophthalmology — Payments: $4,537
Ophthalmology $4,537
Dr. Matthew Gewirtz, M.d, M.D
Ophthalmology — Payments: $2,996
Ophthalmology $2,996
Dr. Marilynn Sultana-Gallick, M.d, M.D
Ophthalmology — Payments: $1,367
Ophthalmology $1,367